Harmony Biosciences Holdings Inc — Quarterly Financial Statistics (NASDAQ:HRMY) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 70.5 M75.56 M33.99 M79.33 M108.73 M126.15 M 348.2 M Cash from investing activities -745 K7.19 M2.36 M14.87 M4.79 M17.63 M 39.65 M Cash from financing activities 1.18 M2.74 M352 K2.69 M3 M3.02 M 9.05 M Free cash flow 70.5 M75.05 M33.86 M79.32 M108.66 M126.04 M 347.89 M

Nachrichten

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

Früherer Generika-Start für Wakix: UBS senkt Kursziel für Harmony Biosciences

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry

Truist bestätigt "Halten"-Rating für Harmony Biosciences mit Kursziel von 25 US-Dollar

Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market